Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Steroid 5alpha-reductase inhibitors for BPH from Schering AG

Nov. 29, 2005

Tolvaptan for autosomal dominant polycystic kidney disease

Nov. 17, 2005

Update on the long-term safety of lanthanum carbonate in dialysis patients

Nov. 15, 2005

SEW-2871: An S1P1 receptor agonist with renoprotective actions in vivo

Nov. 15, 2005

Renoprotective effects of pyridavone

Nov. 15, 2005

Phase I data on the pharmacokinetics and safety of CR-002

Nov. 14, 2005

KRP-103: A new NK1 antagonist for urinary incontinence

Nov. 10, 2005

Not approvable letter for premature ejaculation drug dapoxetine

Nov. 9, 2005

Novel therapeutics for genitourinary disorders claimed in recent Roche patent

Nov. 3, 2005

DPI-221 shows potential as an agent for overactive bladder and urinary incontinence

Nov. 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...